Actinic Keratosis (AK)

DBCOND0065881NeoplasmsSkin and Subcutaneous Tissue Diseases

Actinic Keratosis (AK) is the indication for 6 drugs in DrugBank. It is covered by 7 curated, structured indications.

Also known as
Keratosis, Actinic · Solar keratosis · Actinic Keratosis · Actinic Keratoses
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0518969ICD-10L57.0SNOMED CT156395005MedDRA10000614UMLSC0022602

What you can answer from here — as of October 20, 2026

6Indicated drugsWith each drug's targets and mechanism
Listed above
7Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
276Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Actinic Keratosis (AK) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In